Celladon sets IPO range

Gene therapy company Celladon Corp. (San Diego, Calif.) amended its IPO and now plans to sell 5 million shares at $14-$16. At the $15 midpoint, the company would raise $75 million and be valued at $256.6 million. Celladon proposed to raise up to $86.3 million in the offering last month. JPMorgan; Barclays; Stifel; and Wedbush PacGrow are underwriters. ...